Inventor · disambiguated record
Alex Nivorozhkin
Also filed as: NIVOROZHKIN ALEX
28 granted patents·20 pending applications·125 citations·filing 2002–2025
96Inventor score
Files withCYBIN IRL LTD25AMORSA THERAPEUTICS INC7DRINKSAVVY INC4ONIKIENKO SERGEI B4INOTEK PHARMACEUTICALS CORP3
Top patents by PatentIndex Score
48 records- 0198US11242318B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Feb 8, 2022·38 cites·53 claims
- 0297US11724985B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Aug 15, 2023·7 cites·12 claims
- 0396US11834410B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Dec 5, 2023·5 cites·10 claims
- 0496US11746088B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2022·Granted Sep 5, 2023·5 cites·11 claims
- 0595US11958807B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Apr 16, 2024·3 cites·9 claims
- 0694US10653629B2Single layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2018·Granted May 19, 2020·6 cites·26 claims
- 0794US10252982B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2015·Granted Apr 9, 2019·14 cites·48 claims
- 0893US11613515B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·2 cites·16 claims
- 0993US9285352B2System and method for detection of a contaminated beverageDRINKSAVVY INC·Filed 2014·Granted Mar 15, 2016·15 cites·29 claims
- 1092US11098024B2Methods and related tools for CBD conversion to THCNIVOROZHKIN ALEX·Filed 2020·Granted Aug 24, 2021·3 cites·20 claims
- 1191US12291499B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Granted May 6, 2025·0 cites·17 claims
- 1291US11554100B2Single-layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2020·Granted Jan 17, 2023·2 cites·17 claims
- 1391US2025011282A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 1490US11603348B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2021·Granted Mar 14, 2023·1 cites·16 claims
- 1590US9913803B2Single-layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2014·Granted Mar 13, 2018·12 cites·17 claims
- 1686US10274475B2System and method for detection of a contaminated beverageDRINKSAVVY INC·Filed 2017·Granted Apr 30, 2019·2 cites·20 claims
- 1785US12110272B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2023·Granted Oct 8, 2024·0 cites·18 claims
- 1885US10981859B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·1 cites·24 claims
- 1984US12466783B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsACADIA PHARM INC·Filed 2023·Granted Nov 11, 2025·0 cites·19 claims
- 2083US2025230128A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 2182US2023126298A1Deuyerated tryptamine derivative formulations and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 2279US12240813B2Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2021·Granted Mar 4, 2025·0 cites·20 claims
- 2377US2025154101A1Deuterated tryptamine derivatives and methods of useCYBIN IRL LTD·Filed 2025·Application pending·0 cites
- 2477US2025223273A1Methods and related tools for cbd conversion to thcNIVOROZHKIN ALEX·Filed 2025·Application pending·0 cites
- 2576US12264141B2Methods and related tools for CBD conversion to THCNIVOROZHKIN ALEX·Filed 2021·Granted Apr 1, 2025·0 cites·16 claims
- 2672US7078423B25-Aryltetrazole compounds, compositions thereof, and uses thereforINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Jul 18, 2006·6 cites·50 claims
- 2769US2019250137A1System and method for detection of a contaminated beverageDRINKSAVVY INC·Filed 2019·Application pending·0 cites
- 2868US7087631B2Aryltetrazole compounds, and compositions thereofINOTEK PHARMACEUTICALS CORP·Filed 2003·Granted Aug 8, 2006·3 cites·5 claims
- 2966US2024425451A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 3065US2025082607A2Methods of treating disorders with a psilocybin analogCYBIN IRL LTD·Filed 2024·Application pending·0 cites
- 3164US2010035886A1Parenteral formulations of dopamine agonistsVEROSCIENCE LLC·Filed 2009·Application pending·0 cites
- 3263US9989509B2System and method for detection of a contaminated beverageDRINKSAVVY INC·Filed 2016·Granted Jun 5, 2018·0 cites·23 claims
- 3362US2025360148A1Solid dispersions of psilocybinCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 3461US12122741B2Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2021·Granted Oct 22, 2024·0 cites·13 claims
- 3560US2025213527A1Formulations of psilocybin analogs and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 3659US2024174607A1Psilocybin analogs, salts, compositions, and methods of useCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 3758US2024261306A1Formulations of psilocybinCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 3858US2025205198A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 3955US2025236589A1Therapeutic phenethylamine compositions and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 4053US2025145566A1Phenethylamine derivatives, compositions, and methods of useCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 4152US2024366655A1Combination drug therapiesCYBIN IRL LTD·Filed 2022·Application pending·0 cites
- 4252US2023355583A1Methods for delivery of psychedelic medications by inhalation and systems for performing the methodsCYBIN IRL LTD·Filed 2021·Application pending·0 cites
- 4351US7135491B25-Aryltetrazole compounds and uses thereofINOTEK PHARMACEUTICALS CORP·Filed 2005·Granted Nov 14, 2006·0 cites·13 claims
- 4450US9937241B2Degradation resistant HSP70 formulations and uses thereofONIKIENKO SERGEI B·Filed 2012·Granted Apr 10, 2018·0 cites·13 claims
- 4550US2025051279A1Tryptamine compositions and methodsCYBIN IRL LTD·Filed 2023·Application pending·0 cites
- 4649US9616100B2Methods of use of HSP70 for increased performance or treatment of HSP70 related disordersONIKIENKO SERGEI B·Filed 2014·Granted Apr 11, 2017·0 cites·5 claims
- 4738US9217018B2HSP70 fusion protein conjugates and uses thereofONIKIENKO SERGEI B·Filed 2012·Granted Dec 22, 2015·0 cites·8 claims
- 4838US2013090294A1Novel methods of use of hsp70 for increased performance or treatment of hsp70 related disordersONIKIENKO SERGEI B·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alex Nivorozhkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →